National Institute of Mental Health

Nora Volkow, the director of the National Institute on Drug Abuse (NIDA), said that psychedelic substances have promising potential for therapeutic uses, particularly for treating severe depression, post-traumatic stress disorder (PTSD) and addiction. Accelerating Research At a...

Lifestyle sciences company Mydecine Innovations Group Inc. (CNSX: MYCO) (OTCPK:MYCOF) (FSE: 0NF) confirmed Wednesday it has inked a deal with MindLeap. Under the agreement, the Vancouver-based company — which changed its name from New Leaf Brands ...